Related Experiment Video
Updated: Sep 5, 2025

09:12
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates
Published on: January 30, 2014
16.1K
Microglia Phenotypes in Aging and Neurodegenerative Diseases
Menbere Y Wendimu1, Shelley B Hooks1
1Hooks Lab, Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, GA 30602, USA.
Cells
|July 9, 2022
Summary
Microglia, the brain's immune cells, drive neuroinflammation in neurodegenerative diseases (NDs). Their complex, biphasic role shifts between protective and detrimental, depending on disease context and inflammatory triggers.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Neuroinflammation, driven by microglia, is central to neurodegenerative diseases (NDs).
- Microglia exhibit complex, context-dependent roles, acting as both protective and detrimental forces in disease.
- Chronic microglial activation is observed across various acute and chronic neuropathological conditions.
Purpose of the Study:
- To provide a comprehensive overview of microglial phenotypes and inflammatory responses in health, aging, and NDs.
- To emphasize the heterogeneous microglial responses in conditions like hemorrhagic stroke (HS), Alzheimer's disease (AD), and Parkinson's disease (PD).
- To review potential therapeutic targets for modulating microglial responses.
Main Methods:
- Analysis of translational research in preclinical animal models.
- Examination of bulk and single-cell transcriptome studies from human postmortem samples.
- Review of existing literature on microglial receptors and signaling pathways.
Main Results:
- Microglial responses are heterogeneous and depend on the inflammatory insult's nature, duration, and disease stage.
- Evidence highlights both detrimental and protective microglial phenotypes in pathological conditions.
- Key microglial receptors and signaling pathways are identified as potential therapeutic targets.
Conclusions:
- Understanding microglial heterogeneity is crucial for developing effective therapies for NDs.
- Modulating microglial inflammatory responses offers a promising therapeutic strategy for aging and neurodegeneration.
- Further research into age-, sex-, and species-specific microglial differences is warranted.
Keywords:
Alzheimer’s diseaseParkinson’s diseasehemorrhagic strokemicroglianeurodegenerative diseasesneuroinflammation
